Sema4 Holdings Corp

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Investors weren't happy with the company's Q2 update.

Why Sema4 Holdings Stock Is Sinking Today

85% test-volume growth (excluding COVID-19 tests) compared to same period in 2020

Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights

STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced it will release financial results for the second quarter of 2021 after the market close on Monday, August 16, 2021. On the same day, Eric Schadt, Ph.D., Founder and Chief Executive Officer of Sema4, and Isaac Ro, Chief Financial Officer of Sema4, will host a conference call to discuss financial and operating results at 4:30 p.m. ET.

Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

STAMFORD, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate at two upcoming virtual investor conferences in August. Eric Schadt, Ph.D., Founder and Chief Executive Officer, will participate in a fireside chat at the UBS Genomics 2.0 and MedTech Innovations Summit on Wednesday, August 11, 2021 at 10:00 a.m. ET. The Company will also participate at the Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Tuesday, August 17, 2021.

Sema4 to Participate at Two Upcoming Investor Conferences in August

News for Sema4 Holdings Corp Stock (SMFR)